等待开盘 08-27 09:30:00 美东时间
-0.630
-1.93%
Global E Online shares are trading higher after the company raised its FY2025 s...
08-13 19:01
Global E Online (NASDAQ:GLBE) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 93.55 percent. This is a 146.15 percent increase over losses of $(0.13) per share from
08-13 18:08
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Global-e Online Ltd. announced it will report Q2 2025 financial results before market open on August 13, 2025. A conference call will be held at 8:00 AM ET on the same day. Investors can join via dial-in numbers or a live webcast available on Global-e’s Investor Relations website. A replay will be accessible approximately two hours after the call concludes.
07-29 12:30
Truist Securities analyst Matthew Coad maintains Global E Online (NASDAQ:GLBE) with a Sell and raises the price target from $31 to $32.
07-17 22:17
Universal Electronics Inc - Appoints Richard K. Carnifax as Interim CEO - SEC F...
07-16 18:01
The Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers during the week and a look at the past and future catalysts.
06-28 21:11
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136585934532136961.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Vera Therapeutics(VERA)"买入"评级,目标价从75美元升至85美元</p> <p>• Ascendiant Capital:维持60 Degrees
06-03 09:06
Truist Securities analyst Matthew Coad initiates coverage on Global E Online (NASDAQ:GLBE) with a Sell rating and announces Price Target of $31.
06-02 19:21
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities:维持Mersana Therapeutics(MRSN)"买入"评级,目标价从9美元升至10美元</p> <p>• Guggenheim:维持Cabaletta Bio(CABA)"买入
05-17 08:44